This pathogenic cascade is further substantiated by evidence linking ABCA1 dysfunction to cardiolipin-driven mitochondrial damage and by clinical observations where reduced cholesterol efflux in DKD patients accelerates disease progression (15, 16). This evidence concerns the gene ABCA1 and diabetic kidney disease.